Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication Oxycontin caused a widespread opioid ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s owners and members of the Sackler family for their role in the opioid crisis.

This month’s KELOLAND Living Book Club selection examines the history of the Sackler family, including the founding of Purdue Pharma, its role in the marketing of pharmaceuticals, and the family ...

State AGs have reached a new opioid settlement worth $7.4 billion with Purdue Pharma and its owners. The settlement does not give Sackler family members immunity from future opioid lawsuits.

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local ...

The deal replaces a previous, $6 billion agreement that was rejected last July by the Supreme Court because it would have ...

"Today, we're forcing Purdue and the Sackler family to pay for their role in one of the most devastating public health crises in American history." Numerous U.S. states have sued Purdue Pharma for ...

NEW YORK — Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s owners and members of the Sackler family for their role in the opioid ...